Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$98.98 - $115.74 $2.31 Million - $2.7 Million
23,300 Added 259.58%
32,276 $3.73 Million
Q2 2023

Aug 14, 2023

BUY
$96.34 - $112.38 $529,870 - $618,090
5,500 Added 158.23%
8,976 $923,000
Q1 2023

May 15, 2023

SELL
$107.32 - $113.5 $2,575 - $2,724
-24 Reduced 0.69%
3,476 $379,000
Q4 2022

Feb 14, 2023

BUY
$62.39 - $113.8 $218,365 - $398,300
3,500 New
3,500 $398,000
Q1 2021

May 17, 2021

SELL
$71.83 - $95.48 $264,765 - $351,939
-3,686 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$67.0 - $84.39 $6.94 Million - $8.74 Million
-103,576 Reduced 96.56%
3,686 $269,000
Q3 2020

Nov 16, 2020

BUY
$55.23 - $79.93 $82,845 - $119,895
1,500 Added 1.42%
107,262 $8.33 Million
Q2 2020

Aug 14, 2020

BUY
$30.2 - $56.98 $3.19 Million - $6.03 Million
105,762 New
105,762 $5.88 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.